NTRA Natera, Inc.
Nasdaq · SEC CIK 1604821 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $383.05M 135 sales by 12 insiders
- Filings on record
- 783 since 2021-07-07, latest 2026-09-25 21:35
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Rabinowitz Matthew | EXECUTIVE COB, Dir | — | $124.05M |
| Chapman Steven Leonard | CEO AND Pres, Dir | — | $93.95M |
| BOTHA ROELOF | Dir | — | $34.89M |
| Sheena Jonathan | Dir, CO-FOUNDER | — | $29.84M |
| RABINOWITZ DANIEL | SEC. AND CLO | — | $23.83M |
| Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | — | $22.88M |
| Brophy Michael Burkes | CFO | — | $22.14M |
| ROSENMAN HERM | Dir | — | $15.14M |
| Fesko John | Pres, CHIEF BUS. Off | — | $9.35M |
| Baynes Roy D. | Dir | — | $2.81M |
Transactions 1,059
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-12-13 | 2024-12-13 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | S - Sale | $165.74 | -160.0K | 2.39M | -6% | -$26.52M |
| 2024-12-11 | 2024-12-10 | NTRA | Chapman Rowan E | Dir | S - Sale | $170.24 | -1,767 | 6,202 | -22% | -$300.8K | |
| D | 2024-12-11 | 2024-12-09 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $166.59 | -4,858 | 114.9K | -4% | -$809.3K |
| DM | 2024-12-11 | 2024-12-09 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | A - Grant | $9.43 | +9,075 | 116.4K | +8% | +$85.6K |
| D | 2024-12-09 | 2024-12-05 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | M - OptEx | $5.40 | +68.5K | 2.55M | +3% | +$369.9K |
| MI | 2024-12-04 | 2024-12-02 | NTRA | BOTHA ROELOF | Dir | S - Sale | $169.12 | -87.5K | 1.30M | -6% | -$14.79M |
| MI | 2024-11-27 | 2024-11-25+ | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | S - Sale | $166.35 | -4,000 | 86.3K | -4% | -$665.4K |
| M | 2024-11-21 | 2024-11-19 | NTRA | Marcus Gail Boxer | Dir | S - Sale | $159.98 | -9,682 | 9,704 | -50% | -$1.55M |
| DM | 2024-11-15 | 2024-11-15 | NTRA | Baynes Roy D. | Dir | S - Sale+OE | $146.11 | -37.2K | 47.5K | -44% | -$5.44M |
| DM | 2024-11-15 | 2024-11-15 | NTRA | Baynes Roy D. | Dir | M - OptEx | $23.48 | +37.2K | 53.0K | +236% | +$874.2K |
| M | 2024-11-15 | 2024-11-15 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $146.41 | -4,728 | 186.9K | -2% | -$692.2K |
| M | 2024-11-15 | 2024-11-14 | NTRA | Marcus Gail Boxer | Dir | S - Sale | $158.53 | -2,212 | 21.1K | -9% | -$350.7K |
| MI | 2024-11-15 | 2024-11-13 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $156.48 | -16.3K | 47.8K | -25% | -$2.55M |
| M | 2024-11-15 | 2024-11-13 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $153.54 | -20.0K | 271.7K | -7% | -$3.07M |
| DM | 2024-11-13 | 2024-11-11+ | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | M - OptEx | $5.40 | +140.0K | 2.47M | +6% | +$756.0K |
| M | 2024-11-12 | 2024-11-08 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $130.80 | -2,700 | 282.1K | -0.9% | -$353.2K |
| MI | 2024-11-12 | 2024-11-08 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $130.77 | -3,000 | 56.0K | -5% | -$392.3K |
| 2024-11-01 | 2024-10-31 | NTRA | Brophy Michael Burkes | CFO | S - Sale | $126.45 | -1,866 | 68.9K | -3% | -$236.0K | |
| 2024-10-30 | 2024-10-28 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $118.21 | -3,960 | 189.8K | -2% | -$468.1K | |
| 2024-10-30 | 2024-10-28 | NTRA | Fesko John | Pres, CHIEF BUS. Off | S - Sale | $118.21 | -929 | 113.1K | -0.8% | -$109.8K | |
| 2024-10-30 | 2024-10-28 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $118.21 | -1,196 | 110.7K | -1% | -$141.4K | |
| 2024-10-30 | 2024-10-28 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale | $118.21 | -1,057 | 206.0K | -0.5% | -$124.9K | |
| M | 2024-10-30 | 2024-10-28+ | NTRA | Brophy Michael Burkes | CFO | S - Sale | $118.86 | -1,992 | 70.7K | -3% | -$236.8K |
| 2024-10-29 | 2024-10-25 | NTRA | BOTHA ROELOF | Dir | A - Grant | — | +203 | 3,767 | +6% | — | |
| 2024-10-29 | 2024-10-25 | NTRA | Baynes Roy D. | Dir | A - Grant | — | +124 | 15.8K | +0.8% | — | |
| 2024-10-29 | 2024-10-25 | NTRA | HEALY JAMES | Dir | A - Grant | — | +153 | 46.0K | +0.3% | — | |
| 2024-10-29 | 2024-10-25 | NTRA | ROSENMAN HERM | Dir | A - Grant | — | +178 | 65.8K | +0.3% | — | |
| M | 2024-10-25 | 2024-10-24+ | NTRA | Brophy Michael Burkes | CFO | S - Sale | $119.03 | -1,605 | 72.7K | -2% | -$191.0K |
| M | 2024-10-23 | 2024-10-21+ | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $120.44 | -550 | 112.1K | -0.5% | -$66.2K |
| M | 2024-10-23 | 2024-10-21+ | NTRA | Fesko John | Pres, CHIEF BUS. Off | S - Sale | $120.51 | -541 | 114.1K | -0.5% | -$65.2K |
| D | 2024-10-23 | 2024-10-22 | NTRA | Brophy Michael Burkes | CFO | M - OptEx | — | +1,250 | 74.8K | +2% | — |
| D | 2024-10-23 | 2024-10-23 | NTRA | Brophy Michael Burkes | CFO | S - Sale+OE | $119.09 | -496 | 74.3K | -0.7% | -$59.1K |
| DM | 2024-10-22 | 2024-10-20+ | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | M - OptEx | — | +333 | 282.4K | +0.1% | — |
| DM | 2024-10-22 | 2024-10-20+ | NTRA | Brophy Michael Burkes | CFO | M - OptEx | — | +2,667 | 73.5K | +4% | — |
| DM | 2024-10-22 | 2024-10-21+ | NTRA | Brophy Michael Burkes | CFO | S - Sale+OE | $120.47 | -1,062 | 74.0K | -1% | -$127.9K |
| DM | 2024-10-22 | 2024-10-20+ | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | M - OptEx | — | +1,500 | 207.3K | +0.7% | — |
| DM | 2024-10-22 | 2024-10-21+ | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale+OE | $120.46 | -816 | 207.4K | -0.4% | -$98.3K |
| DM | 2024-10-22 | 2024-10-20+ | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | M - OptEx | — | +5,161 | 196.3K | +3% | — |
| DM | 2024-10-22 | 2024-10-21+ | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale+OE | $120.52 | -2,602 | 194.6K | -1% | -$313.6K |
| 2024-10-17 | 2024-10-15 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $130.40 | -4,523 | 191.2K | -2% | -$589.8K | |
| M | 2024-10-03 | 2024-10-01 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $125.60 | -2,700 | 282.0K | -0.9% | -$339.1K |
| MI | 2024-10-03 | 2024-10-01 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $125.67 | -3,000 | 58.5K | -5% | -$377.0K |
| MI | 2024-09-20 | 2024-09-18 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $127.61 | -19.3K | 58.9K | -25% | -$2.46M |
| M | 2024-09-20 | 2024-09-18 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $127.58 | -2,700 | 285.5K | -0.9% | -$344.5K |
| M | 2024-09-18 | 2024-09-16 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $128.48 | -5,024 | 195.7K | -3% | -$645.5K |
| D | 2024-09-16 | 2024-09-13 | NTRA | Chapman Rowan E | Dir | M - OptEx | $94.14 | +2,614 | 10.6K | +33% | +$246.1K |
| D | 2024-09-16 | 2024-09-13 | NTRA | Chapman Rowan E | Dir | S - Sale+OE | $127.68 | -2,614 | 7,969 | -25% | -$333.8K |
| 2024-08-16 | 2024-08-15 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $121.01 | -12.0K | 287.4K | -4% | -$1.45M | |
| M | 2024-08-16 | 2024-08-15 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $118.92 | -5,583 | 200.7K | -3% | -$663.9K |
| 2024-08-14 | 2024-08-13 | NTRA | Fesko John | Pres, CHIEF BUS. Off | S - Sale | $116.67 | -3,956 | 114.6K | -3% | -$461.5K | |
| 2024-08-14 | 2024-08-12 | NTRA | Fesko John | Pres, CHIEF BUS. Off | A - Grant | — | +10.0K | 118.6K | +9% | — | |
| M | 2024-08-14 | 2024-08-12 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $113.82 | -2,700 | 299.7K | -0.9% | -$307.3K |
| D | 2024-08-09 | 2024-08-08 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | M - OptEx | $5.40 | +190.0K | 1.48M | +15% | +$1.03M |
| 2024-07-31 | 2024-07-29 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale | $102.77 | -1,057 | 206.4K | -0.5% | -$108.6K | |
| 2024-07-31 | 2024-07-29 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $102.77 | -4,084 | 206.3K | -2% | -$419.7K | |
| M | 2024-07-31 | 2024-07-29+ | NTRA | Brophy Michael Burkes | CFO | S - Sale | $100.89 | -3,104 | 72.0K | -4% | -$313.2K |
| D | 2024-07-31 | 2024-07-31 | NTRA | Fesko John | Pres, CHIEF BUS. Off | M - OptEx | $5.40 | +100 | 108.6K | +0.1% | +$540 |
| D | 2024-07-31 | 2024-07-29 | NTRA | Fesko John | Pres, CHIEF BUS. Off | S - Sale+OE | $102.77 | -929 | 108.5K | -0.8% | -$95.5K |
| 2024-07-31 | 2024-07-29 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $102.77 | -1,196 | 112.4K | -1% | -$122.9K | |
| 2024-07-30 | 2024-07-26 | NTRA | HEALY JAMES | Dir | A - Grant | — | +177 | 45.9K | +0.4% | — | |
| 2024-07-30 | 2024-07-26 | NTRA | BOTHA ROELOF | Dir | A - Grant | — | +234 | 3,564 | +7% | — | |
| 2024-07-30 | 2024-07-26 | NTRA | Baynes Roy D. | Dir | A - Grant | — | +143 | 15.7K | +0.9% | — | |
| 2024-07-30 | 2024-07-26 | NTRA | ROSENMAN HERM | Dir | A - Grant | — | +206 | 65.6K | +0.3% | — | |
| M | 2024-07-26 | 2024-07-24+ | NTRA | Brophy Michael Burkes | CFO | S - Sale | $104.39 | -2,359 | 75.8K | -3% | -$246.3K |
| 2024-07-23 | 2024-07-22 | NTRA | Fesko John | Pres, CHIEF BUS. Off | S - Sale | $105.16 | -549 | 109.4K | -0.5% | -$57.7K | |
| 2024-07-23 | 2024-07-22 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $105.16 | -549 | 113.6K | -0.5% | -$57.7K | |
| DM | 2024-07-23 | 2024-07-20+ | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | M - OptEx | — | +1,500 | 207.6K | +0.7% | — |
| D | 2024-07-23 | 2024-07-22 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale+OE | $105.16 | -815 | 207.5K | -0.4% | -$85.7K |
| DM | 2024-07-23 | 2024-07-20+ | NTRA | Brophy Michael Burkes | CFO | M - OptEx | — | +3,917 | 79.0K | +5% | — |
| DM | 2024-07-23 | 2024-07-22+ | NTRA | Brophy Michael Burkes | CFO | S - Sale+OE | $105.88 | -1,558 | 77.9K | -2% | -$165.0K |
| DM | 2024-07-23 | 2024-07-20+ | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | M - OptEx | — | +333 | 302.0K | +0.1% | — |
| D | 2024-07-23 | 2024-07-22 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale+OE | $105.16 | -2,638 | 210.4K | -1% | -$277.4K |
| DM | 2024-07-23 | 2024-07-20+ | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | M - OptEx | — | +5,160 | 213.0K | +2% | — |
| M | 2024-07-17 | 2024-07-15 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $111.65 | -5,496 | 207.9K | -3% | -$613.6K |
| 2024-07-02 | 2024-06-28 | NTRA | Baynes Roy D. | Dir | A - Grant | — | +2,964 | 15.5K | +24% | — | |
| DM | 2024-07-02 | 2024-07-01 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale+OE | $108.10 | -37.5K | 226.8K | -14% | -$4.05M |
| D | 2024-07-02 | 2024-06-28 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | M - OptEx | — | +37.5K | 250.9K | +18% | — |
| 2024-07-02 | 2024-06-28 | NTRA | BOTHA ROELOF | Dir | A - Grant | — | +2,964 | 3,330 | +810% | — | |
| 2024-07-02 | 2024-06-28 | NTRA | HEALY JAMES | Dir | A - Grant | — | +2,964 | 45.7K | +7% | — | |
| 2024-07-02 | 2024-06-28 | NTRA | ROSENMAN HERM | Dir | A - Grant | — | +2,964 | 65.4K | +5% | — | |
| D | 2024-07-02 | 2024-07-01 | NTRA | Brophy Michael Burkes | CFO | S - Sale+OE | $108.37 | -4,983 | 75.1K | -6% | -$540.0K |
| D | 2024-07-02 | 2024-06-28 | NTRA | Brophy Michael Burkes | CFO | M - OptEx | — | +12.5K | 80.0K | +19% | — |
| 2024-07-02 | 2024-06-28 | NTRA | Chapman Rowan E | Dir | A - Grant | — | +2,964 | 7,969 | +59% | — | |
| M | 2024-07-02 | 2024-07-01 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $108.87 | -2,700 | 302.7K | -0.9% | -$293.9K |
| 2024-07-02 | 2024-06-28 | NTRA | Marcus Gail Boxer | Dir | A - Grant | — | +2,964 | 21.6K | +16% | — | |
| D | 2024-07-02 | 2024-06-28 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | M - OptEx | — | +5,000 | 209.5K | +2% | — |
| D | 2024-07-02 | 2024-07-01 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale+OE | $108.37 | -2,723 | 206.8K | -1% | -$295.1K |
| 2024-07-02 | 2024-06-28 | NTRA | Williams Brinkley Ruth | Dir | A - Grant | — | +2,964 | 2,964 | New | — | |
| 2024-06-21 | 2024-06-18 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $109.66 | -2,700 | 304.5K | -0.9% | -$296.1K | |
| M | 2024-06-18 | 2024-06-17 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $111.61 | -6,105 | 213.4K | -3% | -$681.4K |
| 2024-05-31 | 2024-05-30 | NTRA | Marcus Gail Boxer | Dir | S - Sale | $110.17 | -2,000 | 18.6K | -10% | -$220.3K | |
| 2024-05-30 | 2024-05-28 | NTRA | Fesko John | Pres, CHIEF BUS. Off | S - Sale | $109.96 | -1,438 | 109.9K | -1% | -$158.1K | |
| 2024-05-30 | 2024-05-28 | NTRA | Chapman Rowan E | Dir | S - Sale | $109.09 | -4,856 | 5,005 | -49% | -$529.7K | |
| 2024-05-30 | 2024-05-28 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $109.96 | -1,647 | 114.2K | -1% | -$181.1K | |
| MI | 2024-05-24 | 2024-05-23 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $108.30 | -1,000 | 68.6K | -1% | -$108.3K |
| 2024-05-17 | 2024-05-16 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | G - Gift | $0.00 | -11.9K | 307.2K | -4% | $0 | |
| M | 2024-05-17 | 2024-05-15 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $107.08 | -6,779 | 222.8K | -3% | -$725.9K |
| DM | 2024-05-10 | 2024-05-10 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale+OE | $104.59 | -30.0K | 228.5K | -12% | -$3.14M |
| D | 2024-05-10 | 2024-05-10 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | M - OptEx | $19.68 | +30.0K | 234.5K | +15% | +$590.4K |
| D | 2024-05-10 | 2024-05-08 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | M - OptEx | $5.40 | +215.0K | 1.29M | +20% | +$1.16M |
Purchase Sale Sale after option exercise All abbreviations